Adtalem Global Education (NYSE:CVSA) Posts Quarterly Earnings Results, Beats Estimates By $0.25 EPS

Adtalem Global Education (NYSE:CVSA) announced its quarterly earnings data on Thursday. The company reported $1.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25, FiscalAI reports. Adtalem Global Education had a return on equity of 19.98% and a net margin of 12.26%.The firm had revenue of $487.03 million for the quarter. During the same period last year, the business posted $1.92 earnings per share. The firm’s quarterly revenue was up 4.5% compared to the same quarter last year. Adtalem Global Education updated its FY 2026 guidance to 7.950-8.150 EPS.

Adtalem Global Education Trading Up 13.4%

CVSA stock traded up $15.68 during trading on Friday, reaching $132.68. The stock had a trading volume of 702,974 shares, compared to its average volume of 275,810. The firm’s 50 day moving average is $110.78. Adtalem Global Education has a 52 week low of $86.97 and a 52 week high of $156.26. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.68 and a current ratio of 0.68. The company has a market capitalization of $4.58 billion, a price-to-earnings ratio of 20.67, a PEG ratio of 0.99 and a beta of 0.63.

Insider Buying and Selling at Adtalem Global Education

In other Adtalem Global Education news, Director Michael W. Malafronte purchased 15,305 shares of the company’s stock in a transaction dated Tuesday, March 10th. The shares were acquired at an average price of $100.86 per share, for a total transaction of $1,543,662.30. Following the purchase, the director directly owned 16,505 shares of the company’s stock, valued at $1,664,694.30. The trade was a 1,275.42% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In the last 90 days, insiders have acquired 37,236 shares of company stock worth $3,752,866. Company insiders own 2.50% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on CVSA shares. Barrington Research reissued an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a research note on Friday, April 17th. Truist Financial assumed coverage on Adtalem Global Education in a research report on Tuesday, March 24th. They set a “buy” rating and a $130.00 price objective on the stock. Zacks Research downgraded shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Weiss Ratings began coverage on Adtalem Global Education in a research report on Wednesday, February 25th. They set a “hold (c+)” rating for the company. Finally, Wall Street Zen lowered shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a research note on Saturday. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, Adtalem Global Education presently has an average rating of “Moderate Buy” and a consensus price target of $150.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.